The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Use of epigenetic inhibitor screen to identify HDAC1/2 inhibitor as a pro-differentiation therapy in colorectal cancer.
 
Pornlada Likasitwatanakul
No Relationships to Disclose
 
Zhixin Li
No Relationships to Disclose
 
Sandor Spisak
Stock and Other Ownership Interests - Ameplex Ltd; Methylex Gmbh
Patents, Royalties, Other Intellectual Property - DFCI, patent pending
 
Paul Doan
No Relationships to Disclose
 
Pratyusha Bala
No Relationships to Disclose
 
Priscilla Liow
No Relationships to Disclose
 
Malvina Papanastasiou
No Relationships to Disclose
 
Jun Qi
Stock and Other Ownership Interests - Epiphanes; Talus bio; Zentalis
 
Nilay S. Sethi
Consulting or Advisory Role - Astrin Biosciences
Patents, Royalties, Other Intellectual Property - Compositions and methods for treating and/or identifying an agent for treating intestinal cancers 63/208313 filed 6/8/2021